1. Home
  2. NUVL vs LLYVA Comparison

NUVL vs LLYVA Comparison

Compare NUVL & LLYVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$110.87

Market Cap

8.7B

Sector

Health Care

ML Signal

HOLD

LLYVA

Liberty Media Corporation Series A Liberty Live

HOLD

Current Price

$96.72

Market Cap

8.9B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVL
LLYVA
Founded
2017
1991
Country
United States
United States
Employees
228
54700
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.7B
8.9B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
NUVL
LLYVA
Price
$110.87
$96.72
Analyst Decision
Strong Buy
Analyst Count
16
0
Target Price
$134.75
N/A
AVG Volume (30 Days)
454.3K
114.1K
Earning Date
05-08-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1,239.49
$5.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$71.14
$71.12
52 Week High
$113.02
$99.82

Technical Indicators

Market Signals
Indicator
NUVL
LLYVA
Relative Strength Index (RSI) 64.36 57.69
Support Level $97.99 $91.99
Resistance Level $112.61 $98.77
Average True Range (ATR) 3.54 2.73
MACD 0.84 0.04
Stochastic Oscillator 92.70 68.35

Price Performance

Historical Comparison
NUVL
LLYVA

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About LLYVA Liberty Media Corporation Series A Liberty Live

Liberty Live Holdings Inc consists of its ownership in Live Nation, its wholly owned subsidiary Quint and other minority investments. Quint is a provider of premium sports and entertainment experiences. Through exclusive rights agreements with sports leagues, event organizers, and governing bodies, Quint designs, develops, and sells official ticket-inclusive hospitality and single to multi-day experiential packages that may include on or off-site experiences, transportation, and hotel accommodations, with involvement of Quint personnel throughout the multi-day experiences. Live Nation is one of the live entertainment companies in the world, and the producer of live music concerts in the world, based on total fans that attend Live Nation events as compared to events of other promoters.

Share on Social Networks: